Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.
Contributed equally to this work with: Robert Cockburn, Paul N Newton
*To whom correspondence should be addressed. E-mail: firstname.lastname@example.org
Correction: The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
We want your feedback. Do these subject areas make sense for this article? If not, click the flag
next to the incorrect subject area and we will review it. Thanks for your help!
The email address of the corresponding author has changedPosted by plosmedicine
E-letter to submit in response to “Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ (2005) The global threat of counterfeit drugs: why industry and governments must communicatePosted by plosmedicine
The complex problem of Fake Drugs EpidemicPosted by plosmedicine
Ambra 2.9.22 Managed Colocation provided by Internet Systems Consortium.
Send us feedback
California (US) corporation #C2354500, based in San Francisco